<html>
<head>PUBMED IDs for REG3A</head>
<body bgcolor='#C5F0F2'><h1>REG3A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16314847/'>Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.</a> November 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18160850/'>Downregulation of regenerating islet-derived 3 alpha (REG3A) in primary human gastric adenocarcinomas.</a> December 28  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20532728/'>AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.</a> November 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21636701/'>Different gene expression profiles in metastasizing midgut carcinoid tumors.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21636698/'>Simultaneous phenotyping and quantification of Î±-1-antitrypsin by liquid chromatography-tandem mass spectrometry.</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22528125/'>Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation.</a> September 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22727489/'>The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury.</a> October 18  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22849859/'>Activation of the Jak/Stat signalling pathway by leukaemia inhibitory factor stimulates trans-differentiation of human non-endocrine pancreatic cells into insulin-producing cells.</a> January 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23519454/'>REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation.</a> December 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24342613/'>Hes1 promotes the IL-22-mediated antimicrobial response by enhancing STAT3-dependent transcription in human intestinal epithelial cells.</a> March 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25779676/'>REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.</a> June 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26646797/'>Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.</a> November 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26719042/'>Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.</a> June 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26719034/'>Serum procalcitonin levels in combination with (1)H NMR spectroscopy: A rapid indicator for differentiation of urosepsis.</a> October 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26719042/'>Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.</a> June 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26719034/'>Serum procalcitonin levels in combination with (1)H NMR spectroscopy: A rapid indicator for differentiation of urosepsis.</a> October 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27693023/'>A Single-Cell Transcriptome Atlas of the Human Pancreas.</a> October 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27686228/'>The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells.</a> October 1  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27846243/'>Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development.</a> June 22  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27846237/'>Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.</a> June 27  2016<br></body></html>
